No vaccine is available commercially for vaccination of swine against swine influenza. At an ad hoc technical review of swine influenza held in Hyattsville, Md., on May II and 12, 1976, the question was raised as to whether the vaccine to be used in humans (A/New Jersey /76) in the National Influenza Immunization Program would be efficacious in the vaccination of swine against swine influenza. At the close of the meeting, the group recommended that the U.S. Department of Agriculture consider expansion of investigative methods, including vaccines, for control of swine influenza. This report describes the evaluation of influenza A/New Jersey /76 inactivated wholevirus vaccine in neonatal pigs.
Materials and Methods
Neonatal pigs. Three litters of pigs were obtained by hysterectomy and identified by ear notching; a blood sample was obtained from the umbilical cord of each pig at the time of birth. All pigs were born on the same day and were from cross-bred Hampshire-Yorkshire-Poland Challenge of immunity. Influenza A/New Jersey /8/76 seed virus was not available for challenge; therefore, a closely related swine influenza virus was used as the challenge virus. Vaccinated and susceptible control pigs were exposed intranasally at five weeks of age to 5 X 10 6 . 5 50% chick embryo-infectious doses (EID50) [2] of pig-passaged influenza A/swine /Wiscon-5703 sin /1 j 68 virus, i.e., a suspension of infected porcine lung tissue. Nasal swabs were obtained from vaccinated pigs and controls on six consecutive days after challenge. Virus was isolated from nasal samples in embryonated chicken eggs, and viral isolates were confirmed as swine-like influenza virus with use of reference antiserum to AI New Jersey j 8 j 76 virus. All pigs were bled a final time one week after challenge.
HAl tests. The HAl tests [3] were performed on sera obtained from umbilical cord blood, two and four weeks after vaccination and on sera obtained after challenge; Microtiter equipment (Cooke Engineering Co., Alexandria, Va.) was used. Titers of serum HAl antibody were recorded as the reciprocal of the highest dilution of serum that completely inhibited 4 HA units of A/New Jersey /8/76 reference antigen from agglutinating chicken erythrocytes.
Virus neutralization (VN) tests. Sera obtained four weeks after vaccination were inactivated by heat at 56 C for 30 min before sera were diluted from 1:10 through 1:1,000 and mixed with 100 EID50 of influenza A/swine/Taiwanj75 virus. The serum-virus mixtures were incubated at 4 C for 1 hr, and 0.2 ml of each mixture was inoculated allantoically into 10-day-old embryonated eggs and incubated at 35 C for 48 hr. Controls of homologous serum-virus mixtures and virus alone were included in VN tests. The VN ti ter was expressed as the reci procal of the highest dilution of serum that neutralized virus infectivity in eggs.
Results
During the observation period after vaccination, the pigs had diarrhea in excess of that normally encountered in baby pigs fed formula. Since the pigs that were not vaccinated until three days of age had diarrhea before vaccination, the diarrhea observed in the pigs vaccinated on the day of birth probably was not related to vaccination. However, the pigs did not become dehydrated and had excellent appetites throughout the experiment. There were no signs of respiratory infection in vaccinated or control pigs at any time during the experiment.
No HAl antibody was detected in sera obtained from pigs at birth. Table 1 presents the results of HAl tests after vaccination and after challenge and of viral isolation after challenge. Only three pigs had HAl titers of~20 two weeks after vaccination, 11 had HAl titers of < 10, and seven had HAl titers of 10. Eleven pigs had HAl titers of 20 four weeks after vaccination, three had HAl titers of <10, and seven had HAl titers of 10. Twelve of the pigs had HAl titers of~20 on day 7 after challenge, and none had HAl titers of <10. Hemagglutinating viruses that were specifically inhibited by A/New Jersey/8/76 reference antiserum were isolated from the two control pigs and from four of the 21 vaccinated pigs after challenge. Table 1 also presents the VN titers of sera obtained four weeks after vaccination. Five of the 17 sera tested did not have VN antibody.
Discussion
Pigs are immunologically competent even during later fetal development as indicated by their responsiveness to such diversified antigens as viruses [4, 5] and sheep erythrocytes ' [6] . Therefore, the hysterectomy-derived neonatal pigs used in this experiment were satisfactory subjects for evaluation of the influenza A/New Jersey /76 vaccine. The evaluation was based on development and levels of HAl and VN antibodies after vaccination and also on the ability of the virus to be isolated after challenge of immunity.
Two weeks after vaccination, only three pigs had HAl titers of~20; thus, the group geometric mean titer (GMT) was very low. By four weeks after vaccination, HAl titers of the vaccinees increased to a GMT fourfold greater than the value at two weeks. Titers of HAl antibody to the in-8705 activated virus vaccine developed slowly in contrast to the development of titers of 23 and 35 in two herds of pigs by three weeks after natural infection with swine influenza virus [7] . Perhaps this difference in antibody response is due to exposure to a greater amount of antigenic mass during active infection. One suggestion is that pigs vaccinated with 400 CCA units of A/New Jersey/76 virus vaccine had slightly higher HAl antibody titers by the end of four weeks than did those vaccinated with 200 CCA units.
In spite of the relatively low HAl and VN titers in most of the vaccinees, the fact that virus was isolated from only four of the 21 pigs after challenge was encouraging. This result indicates that --80% of the vaccinated pigs were protected. Because virus was not isolated from pigs with relatively low HAl and VN titers but from two pigs with HAl titers of~20, the correlation between HAl and VN titers and immunity to the challenge virus was not positive. The results suggest that humoral antibodies (HAl and VN) do not necessarily reflect the degree of immunity in pigs after vaccination with swine-like influenza virus vaccine.
